Blog
FAQ Category: Patent Law
Procedural, legal, statutory, and regulatory elements of patent law. Sources may include 35 USC, 37 CFR, Manual of Patent Examining Procedure, and other sources.
-
How does the USPTO view the duty of disclosure?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO view claims that refer to figures or tables?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO view the importance of claim definiteness in patent quality?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO verify foreign priority claims in international design applications?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO use the computer readable form (CRF) of the “Sequence Listing”?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO ensure uniformity in reexamination practices?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO treat replacement deposits?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO treat prior art references that are not fully enabling?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
How does the USPTO treat disclosures with additional authors or inventors?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
-
What is the difference in USPTO treatment of defective sequence listings for applications filed before and after January 1, 2022?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This…
Thirty minutes. Chief IP Officer on retainer — and the capital option behind it.
If what you need is something else, we’ll tell you on the same call.